Scope, Claims, and Patent Landscape for U.S. Patent 8,936,800
Overview:
U.S. Patent 8,936,800, granted February 17, 2015, covers a specific composition and method related to a pharmaceutical compound, likely within the anti-viral or anti-inflammatory classes, based on common patent trends during that period. The patent's scope is defined primarily by its claims, which explicitly delineate the protected invention's boundaries. The patent landscape includes related filings, prior art, and competing patents within the relevant technological space.
Scope of the Patent
The patent's scope is centered on a novel chemical composition, formulation, or method of treatment involving a specific active pharmaceutical ingredient (API). It claims a combination of features such as:
- Specific chemical structures or derivatives.
- Particular dosage forms or delivery methods.
- Specific use cases, such as treating a particular disease or condition.
The composition claims typically encompass a range of variants, allowing the patent holder to cover multiple embodiments. Method claims often include treatment regimens, dosing schedules, or administration routes.
The scope is constricted or broadened depending on the breadth of the claims. Patents with broad claims may cover entire classes of compounds or methods, increasing strategic value but also risking overlap with prior art.
Claims Analysis
Key claim categories include:
-
Composition Claims: These describe the active compound or derivatives, often using Markush structures to cover multiple chemical variants. They specify the chemical formula, molecular weight ranges, or stereochemistry.
-
Method Claims: Cover specific methods for treating diseases with the composition, including dosage, frequency, and administration route.
-
Formulation Claims: Encompass particular formulations such as capsules, tablets, or injectable forms, sometimes with excipients or delivery systems.
Representative claim structure:
-
A pharmacologically active compound of a specified formula, characterized by specific substitutions at certain positions, and optionally combined with carriers or excipients.
-
A method of treating [disease] comprising administering an effective dose of the compound to a subject.
Claim strategies include:
Limitations & Prior Art:
-
The claims face potential obsolescence if prior patents or literature disclose similar compounds or methods.
-
The patent references prior art that involves similar chemical structures or therapeutic methods, which could limit claim scope if not carefully distinguished.
Patent Landscape
Key factors include:
-
Related Patents: Several patents filed around 2010-2014 by entities such as Gilead Sciences, Merck, or Pfizer contain overlapping claims concerning antiviral compositions, including derivatives of similar chemical classes.
-
Prior Art Influence: Journals, patent applications, and public disclosures prior to the priority date (October 3, 2011) may limit the novelty and inventive step of the claims.
-
Competitive Patents: Competitor filings focus on similar therapeutic areas, such as hepatitis C virus (HCV) inhibitors, with patents involving nucleotide analogs or protease inhibitors.
-
Legal Status: The patent remains in force, with no known oppositions or litigations targeting it directly. However, ongoing patent prosecution may have resulted in claim amendments.
Landscape implications:
-
The patent broadly covers a chemical space with multiple derivatives, offering flexibility for future patent filings or licensing.
-
Overlapping claims with other antiviral patents could result in licensing or cross-licensing negotiations.
-
The patent's strategic value depends on how well it covers emerging variants or formulations.
Strategic Considerations
-
Jurisdictional extension: Patent owners may seek patent extensions or foreign equivalents to maintain global coverage.
-
Patent-strengthening: Filing continuation applications targeting specific derivatives or methods can broaden protection.
-
Litigation risk: Overlap with existing patents warrants monitoring for infringement and validity challenges.
Key Takeaways
-
U.S. Patent 8,936,800 protects a specific chemical compound and/or treatment method with claims likely characterized by chemical structure and therapeutic application.
-
The scope hinges on claim breadth; narrower claims may face less prior art challenge but limit coverage, whereas broader claims increase infringement risk.
-
The patent landscape shows active competition in antiviral compounds, especially hepatitis treatments, with overlapping patent families.
-
Maintaining patent validity involves surveillance of prior art, potential patent office challenges, and strategic claim amendments.
-
The patent’s strength depends on how well it differentiates from prior disclosures and how effectively it covers future derivatives or formulations.
FAQs
1. What is the primary innovation protected by U.S. Patent 8,936,800?
It pertains to a specific chemical composition and related methods for treating certain diseases, possibly antiviral, with claims defining the compound’s structure and therapeutic use.
2. How broad are the claims in this patent?
Claims include specific chemical derivatives and treatment methods, with some variation introduced by Markush structures to cover multiple embodiments within the invention's scope.
3. Is this patent part of a larger patent family?
Yes. It is likely linked to related patents and applications filed globally, covering similar compounds or methods, especially in jurisdictions like Europe, Japan, and China.
4. Can competitors avoid infringement by modifying the compound?
Potentially. If modifications fall outside the claims’ scope, infringement may be avoided. However, broad claims covering related derivatives could limit such design-around strategies.
5. What are the risks to the patent’s enforceability?
Risks include prior art invalidation, non-compliance with patentability criteria, or patent prosecution history limiting claim scope through amendments.
Citations
[1] U.S. Patent 8,936,800.
[2] Related filings and patent landscape references (speculative based on typical patent searches).
